Suppr超能文献

基于 NanoBiT 的均相配体-受体结合分析。

The NanoBiT-Based Homogenous Ligand-Receptor Binding Assay.

机构信息

Research Center for Translational Medicine at East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, China.

出版信息

Methods Mol Biol. 2022;2525:139-153. doi: 10.1007/978-1-0716-2473-9_10.

Abstract

NanoLuc Binary Technology (NanoBiT) was recently developed by Promega, based on a large NanoLuc fragment (LgBiT) and two small complementation tags, the low-affinity SmBiT tag and the high-affinity HiBiT tag. In recent studies, we applied NanoBiT to ligand-binding assays of some G protein-coupled receptors via genetic fusion of a secretory LgBiT (sLgBiT) to the extracellular N-terminus of the receptors and covalent attachment of the low-affinity SmBiT tag to an appropriate position of their peptide ligands. The NanoBiT-based homogenous ligand-receptor binding assay is convenient for use and suitable for both the wild-type and mutant receptors, representing a novel tool for interaction mechanism studies of these receptors with their ligands. In the present chapter, we provide detailed protocols for setting up the NanoBiT-based homogenous binding assay using growth hormone secretagogue receptor type 1a (GHSR1a) and its endogenous agonist and antagonist as a representative model system.

摘要

NanoLuc Binary Technology (NanoBiT) 是 Promega 公司最近开发的一种技术,它基于一个较大的 NanoLuc 片段(LgBiT)和两个小的互补标签,即低亲和力 SmBiT 标签和高亲和力 HiBiT 标签。在最近的研究中,我们通过将分泌型 LgBiT(sLgBiT)与受体的细胞外 N 端融合,并将低亲和力 SmBiT 标签共价连接到其肽配体的适当位置,将 NanoBiT 应用于一些 G 蛋白偶联受体的配体结合测定。基于 NanoBiT 的均相配体-受体结合测定法方便易用,适用于野生型和突变型受体,是研究这些受体与配体相互作用机制的一种新工具。在本章中,我们提供了使用生长激素促分泌素受体 1a(GHSR1a)及其内源性激动剂和拮抗剂作为代表性模型系统建立基于 NanoBiT 的均相结合测定法的详细方案。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验